Advancements in Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Cancer Treatment: Current Trends and Future Perspectives
Indus Journal of Bioscience Research · 08.05.2026 · 4 (S1) · 149-154
DOI: 10.70749/ijbr.v4is1.3066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indus Journal of Bioscience Research, online erschienen am 08.05.2026. Verfasst von Mohsin Raza und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study was conducted using a quantitative research design to evaluate advancements, current trends, and future perspectives in Chimeric Antigen Receptor T-cell (CAR-T) therapy for cancer treatment. The research was carried out using secondary data collected from peer-reviewed journals, clinical trial reports, and scientific databases, focusing on measurable outcomes such as response rates, remission rates, and incidence of adverse effects. The study was conducted in the Aga Khan University and purposive sampling was used to select the right studies that contained quantitative data on CAR-T therapy. The results indicated that CAR-T therapy was very effective in the treatment of blood cancers; particularly acute lymphoblastic leukemia and diffuse large B-cell lymphoma, and less effective in solid cancers. It also resulted in major side effects, including cytokine release syndrome and neurotoxicity, therefore, posing safety concerns. Nevertheless, the CAR-T cells design, including second-, third-, and fourth-generation cells, proved to be more effective and long-lasting. The study also revealed that the growing technologies like gene editing, the creation of allogeneic CAR-T cells and combination therapies could be used to solve the existing toxicity, cost and accessibility concerns. To sum up, the research revealed that CAR-T is a groundbreaking treatment in cancer therapy, with a promising future, but it requires further development to enhance its therapeutic efficacy and increase its application in cancer patients.
Zitieren
APA
Raza, M., Azam, M., Ashraf, N., Shaker, J., Zarar, K., & Qaiser, A. (2026). Advancements in Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Cancer Treatment: Current Trends and Future Perspectives. Indus Journal of Bioscience Research, 4(S1), 149-154. https://doi.org/10.70749/ijbr.v4is1.3066
Vancouver
Raza M, Azam M, Ashraf N, Shaker J, Zarar K, Qaiser A. Advancements in Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Cancer Treatment: Current Trends and Future Perspectives. Indus Journal of Bioscience Research. 2026;4(S1):149-154. doi:10.70749/ijbr.v4is1.3066
BibTeX
@article{Raza2026,
author = {Raza, Mohsin and Azam, Muhammad and Ashraf, Norab and Shaker, Jawaria and Zarar, Khansa and Qaiser, Abdullah},
title = {Advancements in Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Cancer Treatment: Current Trends and Future Perspectives},
journal = {Indus Journal of Bioscience Research},
year = {2026},
volume = {4},
number = {S1},
pages = {149--154},
doi = {10.70749/ijbr.v4is1.3066}
}
EUVIMED